Pestalozzi advises H.C. Wainwright in connection with private placement in NLS Pharmaceutics Ltd
Pestalozzi advised H.C. Wainwright LLC in connection with a direct offering of 7,000,000 common shares in NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company listed at NASDAQ (Ticker: NLSP/NLSPW) and in a private placement warrants to purchase up to 3'500'000 common shares. H.C. Wainwright & Co., LLC acted as exclusive placement agent for the offering.
Pestalozzi advised H.C. Wainwright & Co. LLC as to all matters of Swiss law.